Atlas Trials

Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)

Clinical trial NCT01510093 · COMPLETED

Trial details

NCT number
NCT01510093
Sponsor
Aarhus University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2012-05-01
Primary completion
2012-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.